The endogenous opioid system: a common substrate in drug addiction.
about
Serotonergic gene variation in substance use pharmacotherapy: a systematic review15 years of genetic approaches in vivo for addiction research: Opioid receptor and peptide gene knockout in mouse models of drug abuseNeurotrophins in the ventral tegmental area: Role in social stress, mood disorders and drug abuseA review of pharmacogenetic studies of substance-related disordersMechanistic insights into nicotine withdrawal.Music and social bonding: "self-other" merging and neurohormonal mechanisms.Acute administration of nicotine into the higher order auditory Te2 cortex specifically decreases the fear-related charge of remote emotional memoriesKnockdown of ventral tegmental area mu-opioid receptors in rats prevents effects of social defeat stress: implications for amphetamine cross-sensitization, social avoidance, weight regulation and expression of brain-derived neurotrophic factor.Central effects of ethanol interact with endogenous mu-opioid activity to control isolation-induced analgesia in maternally separated infant rats.μ-Opioid blockade reduces ethanol effects on intake and behavior of the infant rat during short-term but not long-term social isolation.Introduction to the College on Problems of Drug Dependence special issue: contemporary advances in opioid neuropharmacologyThe role of kappa-opioid receptor activation in mediating antinociception and addiction.Reward, addiction, withdrawal to nicotine.Methamphetamine: an update on epidemiology, pharmacology, clinical phenomenology, and treatment literatureOpioid modulators for alcohol dependence.Sex differences in drug addiction and response to exercise intervention: From human to animal studiesThe effects of alcohol on the pharmacokinetics and pharmacodynamics of the selective mu-opioid receptor antagonist GSK1521498 in healthy subjectsMethylphenidate and μ opioid receptor interactions: a pharmacological target for prevention of stimulant abuse.Human Mu Opioid Receptor (OPRM1 A118G) polymorphism is associated with brain mu-opioid receptor binding potential in smokersInteractions of the opioid and cannabinoid systems in reward: Insights from knockout studies.Mephedrone alters basal ganglia and limbic dynorphin systems.Alcohol dependence, disinhibited behavior and variation in the prodynorphin geneMu-opioid receptor (MOR) expression in the human spiral ganglia.Effect of ΔFosB overexpression on opioid and cannabinoid receptor-mediated signaling in the nucleus accumbens.Endogenous Opioid Signaling in the Medial Prefrontal Cortex is Required for the Expression of Hunger-Induced Impulsive Action.Neuropeptides as mediators of the early-life impact on the brain; implications for alcohol use disorders.Cigarette smoking predicts differential benefit from naltrexone for alcohol dependence.Neurochemical and neurostructural plasticity in alcoholism.Polydrug abuse: a review of opioid and benzodiazepine combination useThe role of endogenous dynorphin in ethanol-induced state-dependent CPP.The HIV-1 transgenic rat model of neuroHIV.Consequences of the 118A>G polymorphism in the OPRM1 gene: translation from bench to bedside?Combination of Levo-Tetrahydropalmatine and Low Dose Naltrexone: A Promising Treatment for Prevention of Cocaine Relapse.Current insights into the mechanisms and development of treatments for heavy drinking cigarette smokersOverview and historical perspective of four papers presented on research related to the endogenous opioid systemTowards a 'Sociorelational' Approach to Conceptualizing and Managing Addiction.Neuronal extracellular signal-regulated kinase (ERK) activity as marker and mediator of alcohol and opioid dependence.Utility of genetically modified mice for understanding the neurobiology of substance use disorders.Noninvasive brain stimulation to suppress craving in substance use disorders: Review of human evidence and methodological considerations for future work.The hypocretin/orexin system: implications for drug reward and relapse.
P2860
Q26799093-40332D33-BA0A-448E-881D-3B6196361C2CQ26824667-74860E1F-28CE-4ECA-941B-4FA508FDAFEDQ26991923-2E344748-B384-4A87-ADE5-1DB7C8CEC33AQ27312296-96D895DB-F4F5-44A4-906F-B7C63BB6CDB0Q27687645-39AC26E5-A15B-4EA9-B54F-F26C3AE883AFQ30367911-9CF41B11-A608-446D-9E9F-B68A64578090Q30391283-6B4BFE96-3360-442C-9E90-607ABC07F5C4Q30392496-964C2551-172D-4C02-9535-F9826C44370FQ30417531-D5898B70-A53A-484B-AE79-FA39D8798A7AQ30443720-6505A175-1A4E-400C-8C93-30014397582AQ33888140-E1E16F6C-C980-4636-9853-45A96ED9D987Q34132638-70BA1A39-6107-48EB-9B0C-44E00C3FFF55Q34173418-8F91F5A2-3EEA-41AD-B152-0CE895FA795AQ34181746-87D05FDC-0C79-4CF3-9750-3D2874227C42Q34190543-2C545977-8472-4897-A01D-8C86C49D4322Q34485446-42E31338-02FE-4A93-ABE9-97A3F3090C66Q34806003-4A8A8361-AD2C-4125-B413-5B1D72491115Q35016913-6BA124C7-C5D2-42C2-823D-B41C2FCDB016Q35021946-25DB4A96-7C4F-41D5-8852-B63B16E15837Q35053193-B2AD2A9F-A62A-4193-946A-B15E05139691Q35186200-16CCBCCC-EDC5-40AF-B99C-3BA81CA58837Q35209258-2A81A47F-C4DA-4DD8-914C-6AADC2F718C8Q35624556-50F60581-0707-44FC-8FF0-08DE512E2404Q35682364-BEC85D1C-65D7-4272-8EE4-B778FB6F272DQ35960396-DF2946B7-A61E-41DD-A55F-2AD0D13DCCC8Q36076157-8355C79E-D0DB-4C91-8275-60013D27DC41Q36133717-C314BA95-4202-4B02-AF1B-5BD936420B38Q36165252-0593F8D4-18B3-469D-9DAD-710E46A84CE7Q36266246-462659C0-A28E-4B47-92ED-BBBF45C20838Q36430042-172FABD1-A11A-428C-8FCE-991D89C24304Q36578522-693C40C7-A635-4511-9897-09C4BF5B60FFQ36821195-B3724E4E-9AF7-4562-BD3F-F4A441EC3EFFQ36852570-7FE8607B-1097-4277-8901-44E5F64F8C69Q36877440-C973670B-3BB0-4552-9162-4523CE84D522Q37146219-1DE12221-14A3-4513-A958-E3C68A65C81DQ37177694-00CF7492-9ADD-4580-A738-E9302FBB8BE8Q37629743-298A1B26-9ED9-4F72-8158-A26AB1DA17B1Q37687946-2A50583F-F8F8-4F94-8D1A-8BF8D178920EQ37720520-1FE4C477-50AE-447D-90F3-6AAF63685376Q37995046-E258FA60-BA2E-45F9-8A8D-F8A01E18C2E8
P2860
The endogenous opioid system: a common substrate in drug addiction.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
2009年學術文章
@zh
2009年學術文章
@zh-hant
name
The endogenous opioid system: a common substrate in drug addiction.
@en
The endogenous opioid system: a common substrate in drug addiction.
@nl
type
label
The endogenous opioid system: a common substrate in drug addiction.
@en
The endogenous opioid system: a common substrate in drug addiction.
@nl
prefLabel
The endogenous opioid system: a common substrate in drug addiction.
@en
The endogenous opioid system: a common substrate in drug addiction.
@nl
P2093
P1476
The endogenous opioid system: a common substrate in drug addiction.
@en
P2093
Fernando Berrendero
José Manuel Trigo
Patricia Robledo
Rafael Maldonado
P304
P356
10.1016/J.DRUGALCDEP.2009.10.011
P577
2009-11-28T00:00:00Z